Insulin aspart, recombinant Subcutaneous and Pepcid Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pepcid Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: famotidine
Brand name: Pepcid, Heartburn Relief, Pepcid AC, Pepcid AC Maximum Strength, Pepcid AC Chewable Tablets, Pepcid Oral Suspension
Synonyms: Pepcid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pepcid AC
- Insulin aspart, recombinant Subcutaneous-Pepcid AC Chewable Tablets
- Insulin aspart, recombinant Subcutaneous-Pepcid AC Maximum Strength
- Insulin aspart, recombinant Subcutaneous-Pepcid Complete
- Insulin aspart, recombinant Subcutaneous-Pepcid Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Peptic Relief
- Pepcid Injection-Insulin degludec
- Pepcid Injection-Insulin Degludec (U-100) Prefilled Pens
- Pepcid Injection-Insulin Degludec (U-100) Vials
- Pepcid Injection-Insulin Degludec (U-200) Prefilled Pens
- Pepcid Injection-Insulin degludec and liraglutide
- Pepcid Injection-Insulin degludec and liraglutide Subcutaneous